Menu
Integrating intensive smoking cessation with low-dose CTscreening among heavy smokers
Summary
The following activities will be carried out to enable assessment of the concrete effect of active cessation campaigns attached to LDCT-screening on smoking prevalence and stage-specific lung cancer incidence among heavy-smokers, and feasibility of these approaches and countries’ abilities to reach the target population without existing registers of those who smoke:
1. Evaluation of the current-state-of art in smoking cessation interventions attached to lung cancer screening in Europe (M1-24).
2. Scan of the spectrum of available, advanced methodologies and technology for smoking cessation (M1-24).
3. Assessment of innovative strategies to reach the heavy-smoking screening target population (M1-24).
4. Development of small-scale, randomised pilots (n=1200 2×600) in two participating countries (Finland and Hungary) to evaluate whether active smoking
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
